Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1

Conditions

Hodgkin Disease 21Lymphoma 13Lung Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Urinary Bladder Neoplasms 5Testicular Neoplasms 3Prostatic Neoplasms 3Melanoma 3Urethral Neoplasms 2Testicular Germ Cell Tumor 2Teratoma 2Lymphoma, Large-Cell, Anaplastic 2Uterine Cervical Neoplasms 1Skin Neoplasms 1Seminoma 1Ovarian Neoplasms 1Ovarian Germ Cell Cancer 1Lymphoma, Large B-Cell, Diffuse 1Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1Leukemia 1Endodermal Sinus Tumor 1Carcinoma, Embryonal 1Adenocarcinoma of Lung 1

Interventions

Etoposide 3Cisplatin 3Bleomycin 3Carboplatin 2sodium thiosulfate 1etoposide phosphate 1Vinblastine 1Taxes 1Surgical Procedures, Operative 1Restraint, Physical 1Paclitaxel 1Ifosfamide 1Cyproheptadine 1Congresses as Topic 1Chemotherapy, Adjuvant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Ovarian Germ Cell Cancer × Vinblastine × Clear all
NCT00274950 2013-09-17

Observation and/or Combination Chemotherapy After Surgery or Biopsy in Treating Young Patients With Extracranial Germ Cell Tumors

National Cancer Institute (NCI)

Phase 3 Unknown
105 enrolled
GenitourinaryGynecologic

Ovarian Germ Cell Cancer, Ovarian Neoplasms, Teratoma, Testicular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡